Craig A. Wheeler's most recent trade in Amicus Therapeutics Inc was a trade of 74,872 Stock Options (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 74,872 | 74,872 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 20,414 | 84,631 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 28,195 | 28,195 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 16,483 | 16,483 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 42,467 | 42,467 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 11,847 | 64,217 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 30,474 | 30,474 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 8,584 | 52,370 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,423 | 45,423 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,671 | 43,786 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 36,111 | 36,111 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Craig A. Wheeler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,115 | 31,115 (0%) | 0% | 0 | Common Stock |